menu

MENU

繁體中文

Contact Us

Menu

Menu

Company

Introduction
Team & Board of Directors
Partners
Investors
Latest News

R&D Pipeline

Overview
Intranasal Vaccines
Asthma Immunotherapy
Respiratory Antiviral Immunotherapy

Company

Introduction

Team & Board of Director

Partners

Investors

Latest News

R&D Pipeline

Overview

Intranasal Vaccines

Asthma Immunotherapy

Respiratory Antiviral Immunotherapy

Contact us

Latest News

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form

August 24, 2021

【MoneyDJ】昱厚生技力推三大主力產品 加速臨床進程與商務發展

Press

July 9, 2021

【環球生技月刊】昱厚新冠鼻噴藥AD17002-SC 獲食藥署核准進IIa期臨床試驗

Press

July 8, 2021

【經濟日報C5】昱厚鼻噴新冠藥 准臨床試驗

Press

July 7, 2021

【財訊快報】首個台灣鼻噴新冠藥，昱厚獲准執行IIa臨床試驗，拼Q4完成收案

Press

July 6, 2021

【Ettoday】昱厚新冠新藥獲准執行IIa期臨床　開始收治輕症患者

Press